According to DataM Intelligence, the Respiratory Syncytial Virus (RSV) Market Size reached USD 1.95 billion in 2024 and is projected to advance to USD 4.54 billion by 2033, expanding at a strong CAGR ...

RSV预防性单抗是国家批准的药品，需要由儿科诊疗能力的医生评估开具处方后，方可前往预防接种门诊注射，谨遵医嘱。同时注射时请携带宝宝的《儿童预防接种证》，宝宝注射RSV预防性单抗将同步登记。

The science is sound and the evidence is clear; immunization plays a crucial role in helping to protect children’s health ...

Vaccination plays a vital role in protecting children from respiratory diseases.

Cold and flu season typically happen during the fall and winter. Though it comes around every year, there's still a lot of ...

Background Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory infections (ALRI) among under-5 ...

An international team of scientists has found compelling evidence that early-infancy infection with respiratory syncytial ...

Wesley Freppel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

This year, emergency departments nationwide are seeing an unusually early surge in very young and elderly patients with respiratory distress, often caused by respiratory syncytial virus or RSV. We ...

Pregnant women and adults over 75 among priority groups for RSV protection as respiratory virus season approaches in Ohio.